AbbVie said JUVMO (tavapadon) tablets are available in 5 mg, 10 mg, and 15 mg strengths, plus a titration pack containing 0.25 mg and 1 mg tablets. The drug was approved for Parkinson's disease earlier today.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.
